Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Silicone Augmentation Rhinoplasty in an Oriental Population

Tham, Colin MB, ChB (Aberdeen), FRCSI*; Lai, Yung-Lung MD; Weng, Chau-Jin MD; Chen, Yu-Ray MD

doi: 10.1097/01.sap.0000141947.00927.49
Original Article
Buy

Aesthetic augmentation rhinoplasty is gaining in popularity among Oriental populations. Despite being widely criticized in the literature, silicone implants remain the most commonly used as a result of their ease of application and lack of donor site morbidity. The authors present 355 consecutive Chinese patients who underwent silicone augmentation rhinoplasty from January 1999 to April 2003. During a mean follow-up period of 160 days, 28 patients (7.9%) developed major complications that required either removal or revision of the implant. The patients who had received the largest volume implants had the highest extrusion and infection rates, indicating that overaugmentation is the main cause. The authors hypothesize that the lower complication rates in Oriental compared with white populations is primarily the result of structural differences in the soft tissue envelope of the nose. In our series of patients, nasal augmentation with silicone implants proved to be effective and safe.

Augmentation rhinoplasty was performed with L-shaped silicone implants on 335 consecutive Chinese patients with 7.9% requiring subsequent removal or revision for extrusion or malposition over an average 160-day follow-up period. Overaugmentation was the most common cause of complications.

From the *Department of Plastic Surgery, Singapore General Hospital, Singapore; and the †Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Taiwan.

Received May 14, 2004 and accepted for publication, after revision, June 13, 2004.

Reprints: Colin Tham, Department of Plastic Surgery, Singapore General Hospital, Outram Road, Singapore 169608, Singapore. (Tel): 65-6321-4794; (fax): 65-6220-9340; E-mail: gplthj@sgh.com.sg.

© 2005 Lippincott Williams & Wilkins, Inc.